Abstract
Maple syrup urine disease (MSUD) or branched-chain α-keto aciduria (BCKA) is an inherited disorder caused by a deficiency of the branched-chain α-keto acid dehydrogenase complex (BCKAD) activity. The blockage of this pathway leads to tissue accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine and their respective keto-acids. The clinical features presented by MSUD patients include ketoacidosis, convulsions, coma, psychomotor delay and mental retardation. The mechanism of brain damage in this disease is still poorly understood. However, an increase in lipid peroxidation in vitro in cerebral cortex of young rats as well as a decrease in the antioxidant defenses has been previously observed. In the present work we evaluated different oxidative stress parameters, named reactive species of thiobarbituric acid (TBARS), total antioxidant reactivity (TAR) and total antioxidant status (TAS) in plasma of MSUD patients in order to evaluate whether oxidative stress is involved in this disorder. We verified a marked increase of plasma TBARS measurements, which is indicative of increased lipid peroxidation, as well as a decrease on plasma TAR reflecting a deficient capacity to efficiently modulate the damage associated with an increased production of reactive species. In contrast, TAS was not changed indicating that the total content of antioxidants in plasma of patients affected by MSUD was not altered. These results suggest that free radical generation is elicited in MSUD and is possibly involved in the pathophysiology of the tissue damage found in this disorder.
Similar content being viewed by others
References
Araújo P, Wassermann GF, Tallini K, Furlanetto V, Vargas CR, Wannmacher CMD, Dutra-Filho CS, Wyse ATS, Wajner M (2001) Reduction of large neutral amino acid level in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529–537
Bem-Menachem E, Kyllerman R, Markleind S (2000) Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res 40:33–39
Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Devl Neuroscience 21:327–332
Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005a) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis Jun 20(2):155–167
Bridi R, Latini A, Braum CA, Zorzi GK, Wajner M, Lissi E, Dutra-Filho CS (2005b) Evaluation of the mechanism involved in leucine-induced oxidative damage in cerebral córtex of young rats. Free Radic Res Jan 39(1):71–79
Buege JA, Aust SD (1978) Microssomal lipid peroxidation. Methods Enzymol 52:302–309
Chuang DT, Shih VE (2001) Maple syrup urine disease (branche-chain ketoaciduria). In: Scriver CR, Beaudt AL, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971–2005
Coitinho AS, de Mello CF, Lima TT, de Bastiani J, Fighera MR, Wajner M (2001) Pharmacological evidence that alpha-keto isovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res 894:68–73
Colome C, SIerra C, Vilaseca MA (2000) Congenital errors of metabolism: Cause of oxidative stress? Med Clin 115(3):111–117
Danner DJ, Elsas JL II (1989) Disorders of branched chain amino acid and keto acid metabolism. In: Scriver CR, Beaudt AL, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 671–692
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421
Fontella FU, Gassen E, Pulrolnik V, Wannmacher CMD, Klein AB, Wajner M, Dutra CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47–54
Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177:751–766
Halliwell B (1994) Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 344:721–724
Halliwell B (2001) Role of free radicals in the neurodegenerative diseases. Drugs Aging 18:685–716
Halliwell B, Gutteridge JMC (2001) Detection of free radicals and others reactive species: Trapping and fingerprinting. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, UK, pp 351–425
Joseph MH, Marsden CA (1986) Amino acids and small peptides. In: Lim CF (ed) HPLC of small peptides. IRL Press, Oxford, pp 13–27
Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Koszma M, Greewood K, Edwards AD, Mehmet H (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane despolarization or cytochrome c release: Implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919–1932
Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, Vihalemm T, Kairane C, Zilmer M (2001) The cerebrocortical areas in normal brain aging and in the Alzheimer’s disease: Noticeable difference in the lipid peroxidation level and in antioxidant defense. Neurochem Res 26:353–361
Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Rad Res Commun 17:299–311
Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18:153–158
Méndez-Álvarez E, Soto-Otero R, Hermida-Aeijeiras A, López-Real AM, Labandeira-García JL (2001) Effects of aluminium and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: Relevance for the pathogenesis of Parkinson’s disease. Biochim Biophys Acta 1586:155–168
Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407–412
Pilla C, Cardozo RFD, Dutra CS, Wyze ATS, Wajner M, Wannmacher CMD (2003) Effect of leucine administration on creatine kinase activity in rat brain. Metab Brain Dis 18:17–25
Przedborski S, Donaldson DBS, Jakowec M, Kish JS, Guttman M, Rosoklija G, Hays AP (1996) Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 39:158–165
Reznick AZ, Packer L (1993) Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G, Albano E, Dianzani MU (eds) Free radicals: From basic science to medicine. Birkhäuser Verlag, Basel, pp 425–437
Schadewaldt P, Wendel U (1997) Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr 156(Suppl 1):S62–S66
Schönberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75
Sgaravatti AM, Rosa RB, Schuck PF, Ribeiro CAJ, Wannacher CMD,Wyse ATS, Dutra-Filho CS, Wajner M (2003) Inhibition of brain energy metabolism by the α-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232–238
Snyderman SE, Norton PM, Roitman E (1964) Maple syrup urine disease with particular reference to diet therapy. Pediatrics 34:454–472
Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin in patient with maple syrup urine disease. Jpn J Exp Med 53:109–116
Tavares RG, Santos CES, Tasca C, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44–49
Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: Interrelationship between branched chain amino-, oxo- and hydroxyacids; implications for treatment; association with CNS dysmelination. J Inherit Metab Dis 15:121–135
Tribble D, Shapira R (1983) Myelin proteins: Degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440–446
Yu T-W, Ong ChN (1999) Lag-time measurement of antioxidant capacity using myoglobin and 2,29-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid): Rationale, application and limitation. Anal Biochem 275:217–223
Zielke HR, Huang Y, Tildon JT, Zielke CL, Baab PJ (1996) Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: Leucine infusion. Dev Neurosci 18:420–425
Acknowledgements
This work was supported by grants from Brazilian National Research Council (CNPq), FAPERGS, and FIPE/HCPA—Brazil.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barschak, A.G., Sitta, A., Deon, M. et al. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis 21, 279–286 (2006). https://doi.org/10.1007/s11011-006-9030-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-006-9030-5